Working… Menu

Safety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02625857
Recruitment Status : Completed
First Posted : December 9, 2015
Last Update Posted : August 9, 2019
Information provided by (Responsible Party):
Janssen Research & Development, LLC